NTLA : Intellia Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-03-04 |
|---|---|---|---|---|
| 2026 | $14.55 | $13.85 | $15.46 | 5.29% |
| 2027 | $18.83 | $15.8 | $22.39 | 36.28% |
| 2028 | $23.04 | $20.29 | $24.04 | 66.75% |
| 2029 | $14.93 | $13.41 | $19.02 | 8.05% |
| 2030 | $13.39 | $13.05 | $13.65 | -3.14% |
| 2031 | $13.15 | $12.53 | $14.11 | -4.81% |
| 2032 | $16.45 | $14.32 | $19.29 | 19.01% |
| 2033 | $23.65 | $19.97 | $25.8 | 71.1% |
| 2034 | $21.17 | $15.43 | $25.58 | 53.19% |
| 2035 | $14.19 | $13.56 | $14.9 | 2.67% |
| 2036 | $13.48 | $13.43 | $13.52 | -2.45% |
The 11 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$25.68 with a high forecast of $48.0 and a low forecast of $14.0.
The average Intellia Therapeutics stock forecast represents a 85.82%
increase from the last price of $13.8199996948242.
For Intellia Therapeutics stock forecast for 2026, 9 predictions are offered for each month of 2026 with average Intellia Therapeutics stock
forecast of $14.55, a high forecast of $15.46, and a low forecast of $13.85.
The average Intellia Therapeutics stock forecast 2026 represents a 5.29%
increase from the last price of $13.8199996948242.
For Intellia Therapeutics stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Intellia Therapeutics stock
forecast of $18.83, a high forecast of $22.39, and a low forecast of $15.8.
The average Intellia Therapeutics stock forecast 2027 represents a 36.28%
increase from the last price of $13.8199996948242.
For Intellia Therapeutics stock forecast for 2029, 12 predictions are offered for each month of 2029 with average Intellia Therapeutics stock
forecast of $14.93, a high forecast of $19.02, and a low forecast of $13.41.
The average Intellia Therapeutics stock forecast 2029 represents a 8.05%
increase from the last price of $13.8199996948242.
For Intellia Therapeutics stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average Intellia Therapeutics stock
forecast of $13.15, a high forecast of $14.11, and a low forecast of $12.53.
The average Intellia Therapeutics stock forecast 2031 represents a -4.81%
decrease from the last price of $13.8199996948242.
For Intellia Therapeutics stock forecast 2032, 12 predictions are offered for each month of 2032 with average Intellia Therapeutics stock
forecast of $16.45, a high forecast of $19.29, and a low forecast of $14.32.
The average Intellia Therapeutics stock forecast 2032 represents a 19.01%
increase from the last price of $13.8199996948242.
For Intellia Therapeutics stock forecast for 2036 (10 year), 3 predictions are offered for each month of 2036 with average Intellia Therapeutics stock
forecast of $13.48, a high forecast of $13.52, and a low forecast of $13.43.
The average Intellia Therapeutics stock forecast 2036 represents a -2.45%
decrease from the last price of $13.8199996948242.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $25.68, and this show a -20.79% decrease in average from the prior price target of the each prediction. Also, this average forecast of $25.68 represents a -21.87% decrease from the past average forecast of $32.87, 6 months ago from 15 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-30 | HC Wainwright & Co. | $25.00 | $18.0000 | Buy |
| 2025-10-28 | Bernstein | $14.0000 | $14.5000 | Market Perform |
| 2025-10-28 | RBC Capital | $21.00 | $14.0000 | Sector Perform |
| 2025-10-28 | Barclays | $26.00 | $24.0000 | Overweight |
| 2025-10-28 | JMP Securities | $33.0000 | $29.0000 | Market Outperform |
| 2025-10-28 | Wells Fargo | $45.00 | $17.0000 | Equal-Weight |
| 2025-10-27 | Chardan Capital | $60.00 | $48 | Buy |
| 2025-10-27 | HC Wainwright & Co. | $30.0000 | $25.0000 | Buy |
| 2025-10-27 | B of A Securities | $36.0000 | $30.0000 | Buy |
| 2025-10-06 | JMP Securities | $33.0000 | Market Outperform | |
| 2025-09-19 | HC Wainwright & Co. | $25.0000 | $30.0000 | Buy |
| 2025-09-19 | JMP Securities | Market Perform | ||
| 2025-08-13 | Guggenheim | $45.00 | $14.0000 | Buy |
| 2025-08-11 | Chardan Capital | $68.0000 | $60 | Buy |
| 2025-08-08 | HC Wainwright & Co. | $30.00 | $25.0000 | Buy |
| 2025-08-08 | Wells Fargo | $50.0000 | $45.0000 | Overweight |
| 2025-08-08 | RBC Capital | $25.0000 | $21.0000 | Outperform |
| 2025-06-16 | HC Wainwright & Co. | $30.0000 | $30.0000 | Buy |
| 2025-06-03 | Canaccord Genuity | $74.0000 | $54.0000 | Buy |
| 2025-05-29 | HC Wainwright & Co. | $30.0000 | $30 | Buy |
| 2025-05-20 | HC Wainwright & Co. | $30.0000 | $30 | Buy |
| 2025-05-19 | Wedbush | $10.0000 | $10.0000 | Neutral |
| 2025-05-12 | Guggenheim | $55.0000 | $45.0000 | Buy |
| 2025-05-09 | Chardan Capital | $68.00 | $68.00 | Buy |
| 2025-05-09 | Citigroup | $14.00 | $10.0000 | Neutral |
| 2025-04-21 | Wolfe Research | $21.0000 | Outperform | |
| 2025-03-05 | HC Wainwright & Co. | $30 | Buy |
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-03-06 | $14.24 | 3.02% |
| 2026-03-09 | $13.71 | -3.70% |
| 2026-03-10 | $13.02 | -5.06% |
| 2026-03-11 | $12.53 | -3.71% |
| 2026-03-12 | $11.51 | -8.14% |
NTLA : Long term Intellia Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Apr. is $13.85 , for 2027 Mar. is $16.63 , for 2030 Mar. is $13.62 , for 2031 Mar. is $12.75 , for 2035 Mar. is $14.40 , and for 2036 Mar. is $13.43.
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Apr. | $13.85 | 0.19% |
| 2026 May. | $13.98 | 0.95% |
| 2026 Jun. | $14.15 | 1.20% |
| 2026 Jul. | $14.30 | 1.08% |
| 2026 Aug. | $14.48 | 1.29% |
| 2026 Sep. | $14.68 | 1.37% |
| 2026 Oct. | $14.91 | 1.54% |
| 2026 Nov. | $15.17 | 1.74% |
| 2026 Dec. | $15.46 | 1.94% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $15.80 | 2.20% |
| 2027 Feb. | $16.18 | 2.43% |
| 2027 Mar. | $16.63 | 2.76% |
| 2027 Apr. | $17.14 | 3.05% |
| 2027 May. | $17.70 | 3.28% |
| 2027 Jun. | $18.31 | 3.46% |
| 2027 Jul. | $18.97 | 3.61% |
| 2027 Aug. | $19.66 | 3.66% |
| 2027 Sep. | $20.37 | 3.60% |
| 2027 Oct. | $21.08 | 3.48% |
| 2027 Nov. | $21.76 | 3.23% |
| 2027 Dec. | $22.39 | 2.87% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $22.91 | 2.35% |
| 2028 Feb. | $23.35 | 1.89% |
| 2028 Mar. | $23.68 | 1.42% |
| 2028 Apr. | $23.92 | 1.02% |
| 2028 May. | $24.04 | 0.49% |
| 2028 Jun. | $24.04 | -0.01% |
| 2028 Jul. | $23.88 | -0.63% |
| 2028 Aug. | $23.57 | -1.32% |
| 2028 Sep. | $23.07 | -2.12% |
| 2028 Oct. | $22.36 | -3.07% |
| 2028 Nov. | $21.43 | -4.18% |
| 2028 Dec. | $20.29 | -5.31% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $19.02 | -6.25% |
| 2029 Feb. | $17.73 | -6.76% |
| 2029 Mar. | $16.55 | -6.65% |
| 2029 Apr. | $15.56 | -5.98% |
| 2029 May. | $14.80 | -4.94% |
| 2029 Jun. | $14.23 | -3.82% |
| 2029 Jul. | $13.83 | -2.79% |
| 2029 Aug. | $13.57 | -1.91% |
| 2029 Sep. | $13.43 | -1.03% |
| 2029 Oct. | $13.41 | -0.11% |
| 2029 Nov. | $13.48 | 0.48% |
| 2029 Dec. | $13.56 | 0.63% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $13.63 | 0.49% |
| 2030 Feb. | $13.65 | 0.16% |
| 2030 Mar. | $13.62 | -0.24% |
| 2030 Apr. | $13.55 | -0.50% |
| 2030 May. | $13.48 | -0.54% |
| 2030 Jun. | $13.41 | -0.47% |
| 2030 Jul. | $13.36 | -0.40% |
| 2030 Aug. | $13.31 | -0.37% |
| 2030 Sep. | $13.26 | -0.40% |
| 2030 Oct. | $13.20 | -0.47% |
| 2030 Nov. | $13.12 | -0.54% |
| 2030 Dec. | $13.05 | -0.59% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $12.96 | -0.63% |
| 2031 Feb. | $12.87 | -0.72% |
| 2031 Mar. | $12.75 | -0.91% |
| 2031 Apr. | $12.62 | -1.07% |
| 2031 May. | $12.53 | -0.68% |
| 2031 Jun. | $12.54 | 0.10% |
| 2031 Jul. | $12.76 | 1.69% |
| 2031 Aug. | $13.33 | 4.51% |
| 2031 Sep. | $13.65 | 2.39% |
| 2031 Oct. | $13.80 | 1.07% |
| 2031 Nov. | $13.94 | 1.02% |
| 2031 Dec. | $14.11 | 1.25% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $14.32 | 1.50% |
| 2032 Feb. | $14.57 | 1.74% |
| 2032 Mar. | $14.86 | 1.99% |
| 2032 Apr. | $15.19 | 2.24% |
| 2032 May. | $15.57 | 2.48% |
| 2032 Jun. | $15.99 | 2.70% |
| 2032 Jul. | $16.45 | 2.88% |
| 2032 Aug. | $16.95 | 3.02% |
| 2032 Sep. | $17.48 | 3.13% |
| 2032 Oct. | $18.04 | 3.23% |
| 2032 Nov. | $18.64 | 3.33% |
| 2032 Dec. | $19.29 | 3.44% |
NTLA : Intellia Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $19.97 | 3.56% |
| 2033 Feb. | $20.71 | 3.68% |
| 2033 Mar. | $21.49 | 3.78% |
| 2033 Apr. | $22.30 | 3.77% |
| 2033 May. | $23.11 | 3.61% |
| 2033 Jun. | $23.86 | 3.29% |
| 2033 Jul. | $24.53 | 2.78% |
| 2033 Aug. | $25.07 | 2.19% |
| 2033 Sep. | $25.46 | 1.58% |
| 2033 Oct. | $25.71 | 0.96% |
| 2033 Nov. | $25.80 | 0.36% |
| 2033 Dec. | $25.75 | -0.18% |
NTLA : Intellia Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $25.58 | -0.68% |
| 2034 Feb. | $25.27 | -1.20% |
| 2034 Mar. | $24.82 | -1.80% |
| 2034 Apr. | $24.19 | -2.53% |
| 2034 May. | $23.37 | -3.37% |
| 2034 Jun. | $22.36 | -4.33% |
| 2034 Jul. | $21.17 | -5.34% |
| 2034 Aug. | $19.85 | -6.21% |
| 2034 Sep. | $18.52 | -6.73% |
| 2034 Oct. | $17.28 | -6.70% |
| 2034 Nov. | $16.23 | -6.07% |
| 2034 Dec. | $15.43 | -4.92% |
NTLA : Intellia Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $14.90 | -3.45% |
| 2035 Feb. | $14.58 | -2.14% |
| 2035 Mar. | $14.40 | -1.19% |
| 2035 Apr. | $14.35 | -0.37% |
| 2035 May. | $14.37 | 0.11% |
| 2035 Jun. | $14.37 | 0.02% |
| 2035 Jul. | $14.30 | -0.50% |
| 2035 Aug. | $14.14 | -1.10% |
| 2035 Sep. | $13.94 | -1.43% |
| 2035 Oct. | $13.75 | -1.31% |
| 2035 Nov. | $13.63 | -0.91% |
| 2035 Dec. | $13.56 | -0.52% |
NTLA : Intellia Therapeutics stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $13.52 | -0.27% |
| 2036 Feb. | $13.49 | -0.23% |
| 2036 Mar. | $13.43 | -0.41% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2026 Apr. is $13.8464741782481 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2027 Mar. is $16.630620386473 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2030 Mar. is $13.6187080812764 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2031 Mar. is $12.7527201724902 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2035 Mar. is $14.4036986125051 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2036 Mar. is $13.4342021741278
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, AIPickup would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2027 Mar. is $16.630620386473
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2026-03-04 is $13.8199996948242 and forecast for 2027 Mar. is $16.63, Intellia Therapeutics stock is a good 1 year investment.
14 Days Historical Data for Intellia Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| NTLA stock price for 2026-02-12 | $11.62 | $11.88 | $11.21 | $11.94 |
| NTLA stock price for 2026-02-13 | $11.87 | $11.54 | $11.54 | $12.32 |
| NTLA stock price for 2026-02-17 | $12.22 | $11.82 | $11.66 | $12.47 |
| NTLA stock price for 2026-02-18 | $12.48 | $12.08 | $12.00 | $12.69 |
| NTLA stock price for 2026-02-19 | $13.04 | $12.21 | $12.10 | $13.08 |
| NTLA stock price for 2026-02-20 | $12.64 | $12.79 | $12.51 | $12.96 |
| NTLA stock price for 2026-02-23 | $13.16 | $12.51 | $12.40 | $13.19 |
| NTLA stock price for 2026-02-24 | $13.58 | $13.46 | $13.11 | $13.84 |
| NTLA stock price for 2026-02-25 | $13.42 | $13.60 | $13.41 | $13.93 |
| NTLA stock price for 2026-02-26 | $14.28 | $14.09 | $12.70 | $14.30 |
| NTLA stock price for 2026-02-27 | $13.78 | $13.84 | $13.57 | $14.29 |
| NTLA stock price for 2026-03-02 | $15.44 | $13.79 | $12.75 | $15.51 |
| NTLA stock price for 2026-03-03 | $13.60 | $14.79 | $13.60 | $14.79 |
| NTLA stock price for 2026-03-04 | $13.82 | $13.98 | $13.41 | $14.12 |